Yet although drug companies are often portrayed by the popular press as the source of all evil in biomedical publishing, just 4% of retractions due to misconduct had declared pharmaceutical ...

With everyday life looking more and more like it did before anyone ever heard of COVID-19, our list of the year’s top retractions—this is our tenth for The Scientist—doesn’t include any ...

Ziresovir is the first antiviral to demonstrate significant clinical efficacy and long-term respiratory benefits in ...